Skip to main content
. Author manuscript; available in PMC: 2013 Jan 30.
Published in final edited form as: Drugs Future. 2011 Sep;36(9):691–711. doi: 10.1358/dof.2011.036.09.1641618

Figure 7.

Figure 7

The patent landscape of HCV NS5A inhibitors. Compound labels and symbols, designating company, correspond to Table III with the chemical structures. Relative compound proximity is determined by chemical similarity; X and Y axes are in Tanimoto distance units. BMS-790052 (BMS_11 in figure) is found near the center of the densest cluster of competitive compounds, also near the center of the overall patent landscape.